1、Annual Report 2014Our mission is to care and cure.We want to discover,develop and successfully market innovative products to prevent and cure diseases,to ease suffering and to enhance the quality of life.We also want to provide a shareholder return that reflects outstanding performance and to adequa
2、tely reward those who invest their money,their time and their ideas in our company.our missionDoug Olson plays with his grandson several years after undergoing experimental therapy for chronic lymphocytic leukemia.The therapy is being developed jointly by the University of Pennsylvania and Novartis.
3、Novartis Annual Report 2014|102 CHAIRMANS LETTER 04 CHIEF EXECUTIVE OFFICERS LETTER06 kEy pERFORMANCE INdICATORS CONSOLIdATEd HIgHLIgHTS08 2014 AT A gLANCESTRATEgIC OVERVIEw 14 Our Environment16 Our Strategy18 Our PortfoliopERFORMANCE 22 Performance Summary 30 Division PerformanceINNOVATION40 Innova
4、tion Overview48 PipelineCORpORATE RESpONSIbILITy56 Managing Corporate Responsibility 57 Expanding Access to Healthcare62 Doing Business ResponsiblyCORpORATE gOVERNANCE REpORT68 Letter from the Chairman70 Summary of Our Corporate Governance Approach71 Our Shares and Our Shareholders76 Our Board of Di
5、rectors87 Our ManagementCOMpENSATION REpORT98 Compensation Committee Chairmans Introduction108 2014 Executive Committee Compensation115 2015 Executive Committee Compensation System117 2014 Board Compensation119 Compensation Governance121 2013 Comparative Information FINANCIAL REpORT128 Operating and
6、 Financial Review158 Novartis Group Consolidated Financial Statements230 Financial Statements of Novartis AGOTHER INFORMATION 244 Key Dates 2015,Contact Information and Forward-Looking Statements contentsCoverMaria Lcia Martins Moreira(left),shortly before undergoing cataract surgery at an eye care